Literature DB >> 17974601

Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine.

Peng Li1, Jieru E Lin, Inna Chervoneva, Stephanie Schulz, Scott A Waldman, Giovanni M Pitari.   

Abstract

Guanylyl cyclase C (GC-C), the receptor for diarrheagenic enterotoxins and the paracrine ligands guanylin and uroguanylin, regulates intestinal secretion. Beyond volume homeostasis, its importance in modulating cancer cell proliferation and its uniform dysregulation early in colon carcinogenesis, reflecting loss of ligand expression, suggests a role for GC-C in organizing the crypt-villus axis. Here, eliminating GC-C expression in mice increased crypt length along a decreasing rostral-caudal gradient by disrupting component homeostatic processes. Crypt expansion reflected hyperplasia of the proliferating compartment with reciprocal increases in rapidly cycling progenitor cells and reductions in differentiated cells of the secretory lineage, including Paneth and goblet cells, but not enteroendocrine cells. GC-C signaling regulated proliferation by restricting the cell cycle at the G(1)/S transition. Moreover, crypt expansion in GC-C(-/-) mice was associated with adaptive increases in cell migration and apoptosis. Reciprocal alterations in proliferation and differentiation resulting in expansion associated with adaptive responses in migration and apoptosis suggest that GC-C coordinates component processes maintaining homeostasis of the crypt progenitor compartment. In the context of uniform loss of GC-C signaling during tumorigenesis, dysregulation of those homeostatic processes may contribute to mechanisms underlying colon cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17974601      PMCID: PMC2111108          DOI: 10.2353/ajpath.2007.070198

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

Review 1.  Guanylyl cyclases and signaling by cyclic GMP.

Authors:  K A Lucas; G M Pitari; S Kazerounian; I Ruiz-Stewart; J Park; S Schulz; K P Chepenik; S A Waldman
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

2.  Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.

Authors:  G M Pitari; M D Di Guglielmo; J Park; S Schulz; S A Waldman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays.

Authors:  D A Notterman; U Alon; A J Sierk; A J Levine
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

4.  Expression of guanylin is downregulated in mouse and human intestinal adenomas.

Authors:  K A Steinbrecher; T M Tuohy; K Heppner Goss; M C Scott; D P Witte; J Groden; M B Cohen
Journal:  Biochem Biophys Res Commun       Date:  2000-06-24       Impact factor: 3.575

5.  Differential role of cyclic GMP-dependent protein kinase II in ion transport in murine small intestine and colon.

Authors:  A B Vaandrager; A G Bot; P Ruth; A Pfeifer; F Hofmann; H R De Jonge
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

6.  Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal.

Authors:  W C Yang; J Mathew; A Velcich; W Edelmann; R Kucherlapati; M Lipkin; K Yang; L H Augenlicht
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

7.  Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin.

Authors:  W J Thompson; G A Piazza; H Li; L Liu; J Fetter; B Zhu; G Sperl; D Ahnen; R Pamukcu
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

8.  Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.

Authors:  K Shailubhai; H H Yu; K Karunanandaa; J Y Wang; S L Eber; Y Wang; N S Joo; H D Kim; B W Miedema; S Z Abbas; S S Boddupalli; M G Currie; L R Forte
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

9.  Mutations in the APC tumour suppressor gene cause chromosomal instability.

Authors:  R Fodde; J Kuipers; C Rosenberg; R Smits; M Kielman; C Gaspar; J H van Es; C Breukel; J Wiegant; R H Giles; H Clevers
Journal:  Nat Cell Biol       Date:  2001-04       Impact factor: 28.824

10.  Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.

Authors:  Peng Li; Stephanie Schulz; Alessandro Bombonati; Juan P Palazzo; Terry M Hyslop; Yihuan Xu; Amy A Baran; Linda D Siracusa; Giovanni M Pitari; Scott A Waldman
Journal:  Gastroenterology       Date:  2007-06-02       Impact factor: 22.682

View more
  69 in total

1.  Molecular staging estimates occult tumor burden in colorectal cancer.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

2.  Sex modulates intestinal transformation by the tumor-suppressor GCC.

Authors:  Peng Li; Stephanie Schulz; Giovanni M Pitari; Scott A Waldman
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

3.  Sex modulates intestinal transformation by the tumor-suppressor GCC.

Authors:  Peng Li; Stephanie Schulz; Giovanni M Pitari; Scott A Waldman
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

Review 4.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

Review 5.  GUCY2C ligand replacement to prevent colorectal cancer.

Authors:  Erik S Blomain; Amanda M Pattison; Scott A Waldman
Journal:  Cancer Biol Ther       Date:  2016-04-22       Impact factor: 4.742

Review 6.  Guanylyl cyclase C as a biomarker in colorectal cancer.

Authors:  Terry Hyslop; Scott A Waldman
Journal:  Biomark Med       Date:  2013-02       Impact factor: 2.851

Review 7.  GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome?

Authors:  P Li; J E Lin; G P Marszlowicz; M A Valentino; C Chang; S Schulz; G M Pitari; Scott A Waldman
Journal:  Drug News Perspect       Date:  2009 Jul-Aug

8.  Enterotoxin preconditioning restores calcium-sensing receptor-mediated cytostasis in colon cancer cells.

Authors:  Giovanni M Pitari; Jieru E Lin; Fawad J Shah; Wilhelm J Lubbe; David S Zuzga; Peng Li; Stephanie Schulz; Scott A Waldman
Journal:  Carcinogenesis       Date:  2008-06-19       Impact factor: 4.944

9.  Receptor guanylyl cyclase C (GC-C): regulation and signal transduction.

Authors:  Nirmalya Basu; Najla Arshad; Sandhya S Visweswariah
Journal:  Mol Cell Biochem       Date:  2009-12-04       Impact factor: 3.396

10.  Lack of guanylate cyclase C results in increased mortality in mice following liver injury.

Authors:  Elizabeth A Mann; Kumar Shanmukhappa; Mitchell B Cohen
Journal:  BMC Gastroenterol       Date:  2010-08-02       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.